Prestige News

Total 66
Number Thumbnail Title Author Date Votes Views
36 Prestige Biopharma IDC Hosts Regional R&D Engagement Tour with BISTEP and Civic Groups
we******** | 2025.07.16 | Votes 0 | Views 348
we******** 2025.07.16 0 348
35 Prestige Biopharma IDC Shares Antibody-Based Drug Research with KAIST Professors
김** | 2025.07.10 | Votes 0 | Views 397
김** 2025.07.10 0 397
34 Prestige Biopharma Highlights PBP1510 Clinical Progress at ASCO 2025
we******** | 2025.06.04 | Votes 0 | Views 643
we******** 2025.06.04 0 643
33 Prestige Biopharma Signs 31 European Licensing and Supply Agreement with Teva for Tuznue®
we******** | 2025.05.26 | Votes 0 | Views 538
we******** 2025.05.26 0 538
32 Prestige Biopharma Publishes Preclinical Study of Biosimilar Tuznue® in SCI Journal Drug in R&D
we******** | 2025.04.16 | Votes 0 | Views 419
we******** 2025.04.16 0 419
31 Busan-Jinhae Free Economic Zone Commissioner Visits Prestige Biopharma IDC to Discuss Biopharma Industry Collaboration
we******** | 2025.04.03 | Votes 0 | Views 314
we******** 2025.04.03 0 314
30 Prestige Biopharma to Present Preliminary Phase 1/2a Results of Pancreatic Cancer Antibody PBP1510 at AACR 2025
we******** | 2025.04.01 | Votes 0 | Views 508
we******** 2025.04.01 0 508
29 Prestige Biopharma Files Patent for Early Pancreatic Cancer Diagnostic Technology
we******** | 2025.01.22 | Votes 0 | Views 343
we******** 2025.01.22 0 343
28 Prestige Biopharma Secures Japanese Patent for Antibody Drug Candidate PBP1710 Targeting Solid Tumors
김** | 2025.01.21 | Votes 0 | Views 384
김** 2025.01.21 0 384
27 Prestige Biopharma Group Accelerates Drug Development with New R&D Hub Backed by KRW 200 Billion Investment
we******** | 2024.11.19 | Votes 0 | Views 577
we******** 2024.11.19 0 577